MERINO: Piperacillin-Tazobactam vs Meropenem for ESBL bacteremia
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients with E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone
Continue readingCategory: ID
ProACT: Procalcitonin-Guided Treatment of Lower Respiratory Tract Infections
Huang DT, Yealy DM, Filbin MR, et al.; ProACT Investigators. Procalcitonin-Guided Use of Antibiotics for Lower Respiratory Tract Infection. N
Continue readingDe-escalating MRSA Coverage in Nosocomial Pneumonia
Outcomes Associated With De-escalating Therapy for Methicillin-Resistant Staphylococcus aureus in Culture-Negative Nosocomial Pneumonia. Cowley MC, Ritchie DJ, Hampton N, Kollef
Continue reading3 Days β-lactam for CAP
Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled,
Continue readingTBTC 31 – 4 month TB regimen
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis. Dorman SE, Nahid P, Kurbatova EV, et al.; AIDS Clinical Trials
Continue readingACTT-1 – Remdesivir
“Remdesivir for the Treatment of Covid-19 — Preliminary Report” J.H. Beigel, et al. and the ACTT-1 Study Group Members N
Continue reading